HR Execs on the Move


 
Oryzon’s MISSION is to identify and manipulate biomarkers -genes and proteins- allowing the development of new therapeutic tools in the quest to improve human health – covering unmet clinical needs- and in benefits for our shareholders. Oryzon’s VISION is to become a world leader company in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.  
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.oryzon.com
  • 245 First Street Suite 1800
    Cambridge, MA USA 02142
  • Phone: 617.444.8786

Executives

Name Title Contact Details

Similar Companies

HealthCore

HealthCore is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pion

Optimizing drug development with innovative instruments & scientific expertise.

Pathalys

Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.

TearScience

TearScience is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthstore Holdings

Our proprietary and vertically integrated technology solutions empower clients to improve patient outcomes and enhance medication adherence through improved access (virtual care and MTM), owned pharmacy infrastructure and physician network, information...